Medical Care
Global Antibody Therapeutics and Blood Antibody Therapeutics Market Research Report 2025
- Apr 16, 25
- ID: 192447
- Pages: 81
- Figures: 87
- Views: 1
The global market for Antibody Therapeutics and Blood Antibody Therapeutics was valued at US$ 230860 million in the year 2024 and is projected to reach a revised size of US$ 442990 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The industry"s leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutics and Blood Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutics and Blood Antibody Therapeutics.
The Antibody Therapeutics and Blood Antibody Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Therapeutics and Blood Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutics and Blood Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutics and Blood Antibody Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The industry"s leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutics and Blood Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutics and Blood Antibody Therapeutics.
The Antibody Therapeutics and Blood Antibody Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Therapeutics and Blood Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutics and Blood Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
IgG1
IgG4
Others
Segment by Application
Autoimmune
Tumor
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutics and Blood Antibody Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2020-2031)
2.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Region
2.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue
3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
3.5 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics Head office and Area Served
3.6 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
3.7 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031)
5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application
5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.2.5 Abbvie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.8.5 Takeda Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.10.5 Biogen Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.11.5 UCB Recent Development
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.12.5 Eli Lilly and Company Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.13.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2020-2031)
2.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Region
2.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue
3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
3.5 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics Head office and Area Served
3.6 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
3.7 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031)
5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application
5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.2.5 Abbvie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.8.5 Takeda Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.10.5 Biogen Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.11.5 UCB Recent Development
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.12.5 Eli Lilly and Company Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
11.13.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of IgG1
Table 3. Key Players of IgG4
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2020-2025)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2026-2031)
Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
Table 22. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 50. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Abbvie Company Details
Table 53. Abbvie Business Overview
Table 54. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 55. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Abbvie Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 60. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Alexion Pharmaceuticals Company Details
Table 78. Alexion Pharmaceuticals Business Overview
Table 79. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Alexion Pharmaceuticals Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Biogen Company Details
Table 93. Biogen Business Overview
Table 94. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. IgG1 Features
Figure 5. IgG4 Features
Figure 6. Others Features
Figure 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Autoimmune Case Studies
Figure 10. Tumor Case Studies
Figure 11. Others Case Studies
Figure 12. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2024
Figure 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2020-2031)
Figure 33. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 49. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 54. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 55. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 57. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 58. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 60. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of IgG1
Table 3. Key Players of IgG4
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2020-2025)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2026-2031)
Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
Table 22. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 50. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Abbvie Company Details
Table 53. Abbvie Business Overview
Table 54. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 55. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Abbvie Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 60. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Alexion Pharmaceuticals Company Details
Table 78. Alexion Pharmaceuticals Business Overview
Table 79. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Alexion Pharmaceuticals Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Biogen Company Details
Table 93. Biogen Business Overview
Table 94. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. IgG1 Features
Figure 5. IgG4 Features
Figure 6. Others Features
Figure 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Autoimmune Case Studies
Figure 10. Tumor Case Studies
Figure 11. Others Case Studies
Figure 12. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2024
Figure 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2020-2031)
Figure 33. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 49. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 54. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 55. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 57. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 58. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 60. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232